1-6 of 6
Luz Tarín-Arzaga
Close
Sort by
Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Camila Peña, Virginia Bove, Eloisa Riva, Patricio Duarte, Cesar Augusto Samanez-Figari, Cristian M Seehaus, Luz Tarin-Arzaga, Seisha Alana Von Glasenapp, Rodrigo Meneces Bustillo, Jule F Vasquez, Marcos Hernandez, Claudia Shanley, Moisés Manuel Gallardo-Pérez, Guillermo José Ruiz-Arguelles, Romina Mariano, Virginia Gilli, David Israel Garrido, Patricia Graffigna, Natalia Paola Schutz, Dorotea Fantl
Journal: Blood
Blood (2023) 142 (Supplement 1): 3352.
https://doi.org/10.1182/blood-2023-185240
Published: 2023
Journal Articles

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Eliezer Tomas Tomas Gomez Gomez, David Gomez Almaguer, Cesar Homero Gutierrez-Aguirre, Perla R.R. Colunga-Pedraza, Luz Tarin-Arzaga, Jose Carlos Jaime, Edgar Ulises Coronado, Fernando De La Garza, Estefania Guadarrama Rendon, Santiago Calzada Davila
Journal: Blood
Blood (2022) 140 (Supplement 1): 7710–7711.
https://doi.org/10.1182/blood-2022-163772
Published: 2022
Journal Articles

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Perla Rocío Colunga-Pedraza, MD, Alejandra Garza-Ledezma, MD, Julia Colunga-Pedraza, Olga Cantu-Rodriguez, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Erika Cazares-Rendón, Erick J Rendón-Ramírez, MD, Cesar Homero Gutierrez-Aguirre, MD, Luz Tarin-Arzaga, MD, David Gomez-Almaguer, MD
Journal: Blood
Blood (2016) 128 (22): 5528.
https://doi.org/10.1182/blood.V128.22.5528.5528
Published: 2016
Journal Articles

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

Clinical Trials & Observations Brief Report
David Gómez-Almaguer, Miguel A. Herrera-Rojas, José C. Jaime-Pérez, Andrés Gómez-De León, Olga G. Cantú-Rodríguez, César H. Gutiérrez-Aguirre, Luz Tarín-Arzaga, Jesús Hernández-Reyes, Guillermo J. Ruiz-Arguelles
Journal: Blood
Blood (2014) 123 (25): 3906–3908.
https://doi.org/10.1182/blood-2014-01-549360
Published: 2014
Journal Articles

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

Brief Report
David Gómez-Almaguer, Manuel Solano-Genesta, Luz Tarín-Arzaga, José Luis Herrera-Garza, Olga Graciela Cantú-Rodríguez, César Homero Gutiérrez-Aguirre, José Carlos Jaime-Pérez
Journal: Blood
Blood (2010) 116 (23): 4783–4785.
https://doi.org/10.1182/blood-2010-06-291831
Published: 2010
Journal Articles

Alemtuzumab in the Treatment of Steroid Refractory Acute Graft-Versus-Host Disease.

David Gomez-Almaguer, Guillermo Ruiz-Arguelles, Oscar Gonzalez-Llano, Olga G. Cantu, Cesar H. Gutierrez, Jose Carlos Jaime-Perez, Luz Tarin-Arzaga, Sergio Giralt
Journal: Blood
Blood (2006) 108 (11): 5294.
https://doi.org/10.1182/blood.V108.11.5294.5294
Published: 2006